Sinus Tissue Resection Devices Market Size & Share 2025 – 2034

Sinus Tissue Resection Devices Market Size

The global sinus tissue resection devices market size was valued at USD 1.1 billion in 2024 and is expected to exhibit growth at a CAGR of 6.7% from 2025 to 2034 period. Surgical tools for the resection of sinus tissue are a type of powered surgical instrument used for the excison or reduction of obstructions in the sinuses structures during surgery.

These instruments include but are not limited to, microdebriders which are used for powered instrumentation and manual tools, such as forceps and curettes that are used to enhance sinus drainage and counter chronic sinusitis and nasal polyps. The growth of the market is high because of the increased number of ENT surgeries, ongoing improvements in surgical technology, and increased contributions for development and research, among other reasons.

Moreover, ample market growth is mirrored in the increasing number of ENT clinical procedures performed. Additionally, conductive tissue destruction procedures have showcased promising results in the treatment of chronic sinusitis and nasal polyps, leading to effortless sinus drainage, making it more desirable for patients. The rising number of patients suffering from chronic sinusitis coupled with the favorable market conditions has intensified the demand for surgical procedures and treatment. For instance, in the year 2021, roughly 31.2 million people were reported to suffer from sinusitis, yielding 12% of the adult U.S. population.
 

In addition, minimally invasive surgical options have also acted as a catalyst in this immense growth, with endoscopic sinus surgeries being a prominent example. The development showcases a collective effort into improving patient outcomes by reducing the pain associated with the procedures while still being effective. By shortening the recovery time associated with these types of interventions, growth in the market can be anticipated.
 

Sinus Tissue Resection Devices Market Trends

The market for sinus tissue resection devices is growing rapidly, fuelled by factors such as continuous innovation, the rising demand for integrated robotic-assisted surgeries and automated systems, and the growing incorporation of artificial intelligence in healthcare, among others that are propelling industry growth.
 

• One of the most important trends in the market is the growing popularity of endoscopic sinus surgery, which allows for tissue resection to be done with less extensive incisions than traditional methods and is increasingly sought after. These procedures ensure a faster recovery time, fewer chances for complications, and much more favorable results, which in turn promotes the usage of advanced sinus tissue resection devices.
   

• In addition, there is an increasing penetration of computer-assisted navigation systems in sinus surgery. This technology provides 3D imaging of a detailed picture of the structures and maps them in relation to other structures of the body. Surgeons can visualize the detail of the anatomy better, making the procedures faster and less prone to complications. Further, these will aid the region’s market growth.
   

Sinus Tissue Resection Devices Market Analysis

Based on product type, the market is classified into surgical instruments, endoscopes, surgical navigation systems, and other product types. The surgical instruments segment generated the highest revenue of USD 472.8 million in 2024.
 

• With the advent of robotic-assisted tools and the use of laser technology and high-definition endoscopes, sinus tissue resection techniques are evolving, widening the efficiency and effectiveness of these methods. Such innovations lead to better results and make procedures less complicated than they previously were. Such tools are in high demand, especially with the recent surge of minimally invasive methods.
   
• Also, there is an increasing need for these instruments to be made to measure based on the requirements of the sinus surgery. Instruments like modular forceps and suction devices have better capability to reach the target area and reduce the chances of error. The market for devices that are used for sinus tissue resection is booming, as there is an increased demand for tools that are specifically made to address certain healthcare providers’ strategies or even the patient’s condition.
   

Based on procedure, the sinus tissue resection devices market is classified into functional endoscopic sinus surgery (FESS), balloon sinuplasty, Caldwell Luc surgery, and open sinus surgery. The FESS segment dominated the market in 2024 with a market share of 50.6%.
 

• FESS offers better surgical effectiveness compared to the traditional sinus surgeries. The usage of endoscopes ensures that the surgeons have a clear and wide view of the sinuses along with any other anatomical structures, allowing them to be precise while resecting body tissues. Therefore, better drainage of sinuses, low chances of the symptoms resurfacing, and lower rates of complications are some of the ends achieved in FESS.
   
• Additionally, the continuing evolution of endoscopic technology in the form of high-resolution cameras, 3D imaging, and better light sources has made the use of FESS more efficient. With the aid of such technology, more complex procedures are done by the surgeons and hence explains the FESS rising in popularity and being increasingly used in sinus tissue resection. This trend is likely to further the growth in this segment of the market.
   

Based on application, the sinus tissue resection devices market is classified into chronic sinusitis, recurrent acute sinusitis, benign sinus tumors, and other applications. The chronic sinusitis segment accounted for USD 495.5 million in market revenue in 2024 and is anticipated to grow at a CAGR of 6.2% between the 2025 to 2034 period.
 

• Among the most common long-standing diseases encountered globally, chronic sinusitis is rough to manage as it is characterized by a continued stuffy nose, facial pain, large amounts of pressure, and constant headaches, which has come to affect millions. The rising prevalence of this condition is partly due to allergies, pollution, bacterial infections, and structural problems, which creates a demand for suitable management. With it being a well-documented fact that medications rarely help with chronic sinusitis alone, surgery becomes the next step, which only enhances the market of sinus tissue resection devices.
   
• Moreover, while antibiotics, nasal corticosteroids, and saline irrigation are regular features in the treatment of sinusitis, such treatment must soon be changed as these methods are failing to reap fruits in patients suffering from chronic sinusitis. Unfortunately, this results in shifting in place a strong need to surgically resect sinus tissue, paving the way for increased growth in the surgical market for sinusitis. This in turn also explains the continued growth in advanced equipment required to perform the procedure.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the sinus tissue resection devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 1.1 billion by the end of the forecast period.
 

• Over the last few years, hospitals have installed greater demand for newer technologies in the sinus tissue resection devices like robotic-assisted surgical tools, high-definition endoscopes, and advanced imaging systems. Not only this, the 3D navigation tool that was included sped up the process while also ensuring heightened accuracy. Such innovations answer the demand from hospitals for superior equipment owing to the greater patient outcome. The rising development of surgical devices in the market will only aid further in adoption by hospitals.
   
• Moreover, due to the increasing demand for specialized devices, minimally invasive surgical procedures are being more and more implemented. The employment of such techniques as FESS comes with many benefits such as minimal trauma to the patient, faster recovery, reduced pain, and lower complications. The use of such modified techniques is on the rise in most hospitals, which is resulting in demand for devices that can be employed to carry out precise and lower trauma procedures for sinus surgeries.
   

U.S. sinus tissue resection devices market accounted for USD 406.7 million market revenue in 2024 and is anticipated to grow at a CAGR of 6.1% between the 2025 to 2034 period.
 

• The healthcare system in the U.S. is robust regarding technology as they have modern hospitals, research centers, and medical institutions. Such a wide and robust system enables the use of sophisticated technologies, which are essential in ensuring that surgeries are successful. U.S. healthcare facilities are quick to adopt new medical technologies, and this improves the appetite for new sinus resection devices.
   
• Furthermore, the U.S. market stands out in terms of meeting the international benchmarks in the adoption and integration of advanced medical equipment. Investments made in high-definition endoscopic systems, 3D imaging systems, robotic surgical tools, and computer navigation systems have greatly increased the accuracy of sinus surgery and improved patient outcomes. Such advancements enhance the safety and efficacy of sinus tissue resection procedures, resulting in greater utilization across the country.
   

Germany sinus tissue resection devices market is projected to grow remarkably in the coming years.
 

• Germany’s market is anticipated to witness exceptional growth in the next coming years. Also, the German healthcare system is among the best, where most of the medical services, including chronic sinusitis and disorders of the sinus surgery, are subsidized through public health insurance. In combination with reimbursement policies adopted for enhanced healthcare procedures such as FESS, this comprehensive coverage makes such treatments affordable to a large section of the population.
   
• Moreover, the hospital industry in the country is more likely to invest in advanced equipment due to the government’s undertaking to provide high-quality care for patients. This concentration on new ideas improves investments in cutting-edge sinus tissue resection devices, which increases accuracy and results of surgeries involving sinuses. These important factors ensure steady expansion of the market for sinus tissue resection devices in Germany.
   

Japan holds a dominant position in the Asia Pacific sinus tissue resection devices market.
 

• In Asia-Pacific, Japan’s sinus tissue resection devices' robust business growth is influenced by the rise in the population of 65 years and older. Chronic sinusitis, nasal polyps, and other sinus-related illnesses become more troublesome for this age group, requiring surgery for a cure; hence, surgery on the resection of sinus tissue becomes imperative.
   
• In addition, Japan’s prowess in being one of the best in surgical instruments extends to sinus tissue resection devices as well. The above-mentioned devices, right from HD endoscopes to robotics and computer navigation, are intricately embedded into devices. With these features, the safety and accuracy of the procedures have improved, and consequently, their acceptance in hospitals across the country has grown.
   

Sinus Tissue Resection Devices Market Share

With major manufacturers providing cutting-edge surgical tools and systems for sinus procedures, the market for sinus tissue resection devices is highly competitive. Among the leading businesses in this field are B. Braun, Johnson & Johnson, Stryker, and Medtronic. These businesses compete based on innovation, product quality, and expanding their market share through alliances, strategic acquisitions, and research and development expenditures. Competition in the market is also driven by the increasing emphasis on less invasive procedures and advanced surgical technologies.
 

Sinus Tissue Resection Devices Market Companies

Prominent players operating in the sinus tissue resection devices industry include:

• Acclarent
• B. Braun
• Bien-Air
• Cook Medical
• INTEGRA
• Medtronic
• Meril
• OLYMPUS
• Osteogenics
• PENTAX MEDICAL
• STILLE
• Stryker
• SUMMIT MEDICAL
• SURTEX
• XELPOV SURGICAL

• Strong focus on integrating advanced imaging and navigation systems for superior precision and patient safety.
   
• Recognized for offering affordable and reliable resection solutions, making them accessible to a wide range of healthcare facilities worldwide.
   
• Extensive global presence and trusted for their consistent quality in ENT surgical instruments and devices.
   

Sinus Tissue Resection Devices Industry News: 

• In March 2024, Olympus expanded its ENT portfolio with the launch of the CELERIS single-use sinus debrider system and Celon Elite, targeting outpatient care for rhinology procedures. These innovations support the transition of non-urgent surgeries, such as polypectomies and functional endoscopic sinus surgery, from ORs to office settings. This system, uniquely positioned as the only single-use sinus debrider, enhances efficiency in ENT procedures.
   

The sinus tissue resection devices market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Surgical instruments
• Endoscopes
• Surgical navigation systems
• Other product types

Market, By Procedure

• Functional endoscopic sinus surgery (FESS)
• Balloon sinuplasty
• Caldwell Luc surgery
• Open sinus surgery

Market, By Application

• Chronic sinusitis
• Recurrent acute sinusitis
• Benign sinus tumors
• Other applications

Market, By End Use

• Hospitals
• Specialty clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE